These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26579065)

  • 1. Retrospective Evaluation of Deep Transcranial Magnetic Stimulation as Add-On Treatment for Parkinson's Disease.
    Torres F; Villalon E; Poblete P; Moraga-Amaro R; Linsambarth S; Riquelme R; Zangen A; Stehberg J
    Front Neurol; 2015; 6():210. PubMed ID: 26579065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive deep transcranial magnetic stimulation for motor symptoms in Parkinson's disease: A feasibility study.
    Cohen OS; Orlev Y; Yahalom G; Amiaz R; Nitsan Z; Ephraty L; Rigbi A; Shabat C; Zangen A; Hassin-Baer S
    Clin Neurol Neurosurg; 2016 Jan; 140():73-8. PubMed ID: 26658034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia: Beyond an Antidepressant Effect.
    Linsambarth S; Jeria A; Avirame K; Todder D; Riquelme R; Stehberg J
    J ECT; 2019 Dec; 35(4):e46-e54. PubMed ID: 31764455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study.
    Spagnolo F; Volonté MA; Fichera M; Chieffo R; Houdayer E; Bianco M; Coppi E; Nuara A; Straffi L; Di Maggio G; Ferrari L; Dalla Libera D; Velikova S; Comi G; Zangen A; Leocani L
    Brain Stimul; 2014; 7(2):297-300. PubMed ID: 24300835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: A preliminary dose-finding study exploring safety and clinical effectiveness.
    Thai M; Nair AU; Klimes-Dougan B; Albott CS; Silamongkol T; Corkrum M; Hill D; Roemer JW; Lewis CP; Croarkin PE; Lim KO; Widge AS; Nahas Z; Eberly LE; Cullen KR
    J Affect Disord; 2024 Jun; 354():589-600. PubMed ID: 38484878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.
    Levkovitz Y; Harel EV; Roth Y; Braw Y; Most D; Katz LN; Sheer A; Gersner R; Zangen A
    Brain Stimul; 2009 Oct; 2(4):188-200. PubMed ID: 20633419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment.
    Girardi P; Rapinesi C; Chiarotti F; Kotzalidis GD; Piacentino D; Serata D; Del Casale A; Scatena P; Mascioli F; Raccah RN; Brugnoli R; Digiacomantonio V; Ferri VR; Ferracuti S; Zangen A; Angeletti G
    World J Biol Psychiatry; 2015 Jan; 16(1):66-73. PubMed ID: 25140585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can deep transcranial magnetic stimulation (DTMS) be used to treat substance use disorders (SUD)? A systematic review.
    Kedzior KK; Gerkensmeier I; Schuchinsky M
    BMC Psychiatry; 2018 May; 18(1):137. PubMed ID: 29776355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders.
    Rapinesi C; Kotzalidis GD; Ferracuti S; Girardi N; Zangen A; Sani G; Raccah RN; Girardi P; Pompili M; Del Casale A;
    Neurosci Lett; 2018 Apr; 671():128-132. PubMed ID: 29454034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and neurophysiological effects of dual-target high-frequency rTMS over the primary motor and prefrontal cortex in Parkinson's disease].
    Aftanas LI; Brack IV; Kulikova KI; Filimonova EA; Dzemidovich SS; Piradov MA; Suponeva NA; Poidasheva AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(5):29-36. PubMed ID: 32621465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.
    McGirr A; Van den Eynde F; Chachamovich E; Fleck MP; Berlim MT
    Neurosci Lett; 2014 Mar; 563():144-8. PubMed ID: 24486892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.
    Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Yokoe M; Yoshimine T; Saitoh Y
    Brain Stimul; 2013 Nov; 6(6):884-91. PubMed ID: 23769414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on deep Transcranial Magnetic Stimulation (dTMS) for the treatment of chronic migraine: A preliminary study.
    Rapinesi C; Del Casale A; Scatena P; Kotzalidis GD; Di Pietro S; Ferri VR; Bersani FS; Brugnoli R; Raccah RN; Zangen A; Ferracuti S; Orzi F; Girardi P; Sette G
    Neurosci Lett; 2016 Jun; 623():7-12. PubMed ID: 27132086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning and deep transcranial magnetic stimulation (DTMS) in major psychiatric disorders: A systematic review.
    Kedzior KK; Gierke L; Gellersen HM; Berlim MT
    J Psychiatr Res; 2016 Apr; 75():107-15. PubMed ID: 26828370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease.
    Shin HW; Youn YC; Chung SJ; Sohn YH
    J Neurol; 2016 Jul; 263(7):1442-8. PubMed ID: 27178002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): a 6-month, open label, follow-up study.
    Rapinesi C; Curto M; Kotzalidis GD; Del Casale A; Serata D; Ferri VR; Di Pietro S; Scatena P; Bersani FS; Raccah RN; Digiacomantonio V; Ferracuti S; Bersani G; Zangen A; Angeletti G; Girardi P
    J Affect Disord; 2015 Mar; 174():57-63. PubMed ID: 25484178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral deep transcranial magnetic stimulation of motor and prefrontal cortices in Parkinson's disease: a comprehensive review.
    Hanlon CA; Lench DH; Pell G; Roth Y; Zangen A; Tendler A
    Front Hum Neurosci; 2023; 17():1336027. PubMed ID: 38328677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Hesel-coil deep transcranial magnetic stimulation for depression - a systematic review.
    Nordenskjöld A; Mårtensson B; Pettersson A; Heintz E; Landén M
    Nord J Psychiatry; 2016 Oct; 70(7):492-7. PubMed ID: 27093104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.